| Current development and practice of pharmacoeconomic evaluation guidelines for universal health coverage in China X Yue, Y Li, J Wu, JJ Guo Value in health regional issues 24, 1-5, 2021 | 51 | 2021 |
| Utilization, spending, and price trends for quinolones in the US Medicaid programs: 25 years’ experience 1991–2015 ZS Almalki, X Yue, Y Xia, PR Wigle, JJ Guo PharmacoEconomics-Open 1, 123-131, 2017 | 34 | 2017 |
| Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007–2014 X Yue, JM Pruemer, AL Hincapie, ZS Almalki, JJ Guo Journal of gynecologic oncology 31 (4), 2020 | 29 | 2020 |
| The burden of hypoglycemia in patients with insulin-treated diabetes mellitus in China: analysis of electronic medical records from 4 tertiary hospitals X Yue, J Wu, Z Ruan, ML Wolden, L Li, Y Lin Value in health regional issues 21, 17-21, 2020 | 20 | 2020 |
| Analyzing patient secure messages using a fast health care interoperability resources (FIHR)–based data model: development and topic modeling study A De, M Huang, T Feng, X Yue, L Yao Journal of medical Internet research 23 (7), e26770, 2021 | 19 | 2021 |
| Off-label medication use in rare pediatric diseases in the United States A Fung, X Yue, PR Wigle, JJ Guo Intractable & Rare Diseases Research, 2021 | 18 | 2021 |
| Trends in utilization, spending, and prices of smoking-cessation medications in Medicaid programs: 25 years empirical data analysis, 1991–2015 X Yue, JJ Guo, PR Wigle American Health & Drug Benefits 11 (6), 275, 2018 | 17 | 2018 |
| The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review Z Ruan, L Yang, H Shi, X Yue, Y Wang, M Liang, H Hu Expert review of pharmacoeconomics & outcomes research 21 (2), 221-233, 2021 | 13 | 2021 |
| Prescribing patterns and impact of factors associated with time to initial biologic therapy among children with non-systemic juvenile idiopathic arthritis X Yue, B Huang, AL Hincapie, PR Wigle, T Qiu, Y Li, EM Morgan, JJ Guo Pediatric Drugs 23, 171-182, 2021 | 9 | 2021 |
| Comparative effectiveness and persistence of TNFi and non-TNFi in juvenile idiopathic arthritis: a large paediatric rheumatology centre in the USA X Yue, B Huang, AL Hincapie, PR Wigle, Y Li, T Qiu, DJ Lovell, ... Rheumatology 60 (9), 4063-4073, 2021 | 7 | 2021 |
| Comparative effectiveness research using electronic health records data: ensure data quality B Huang, T Qiu, C Chen, A Neace, Y Zhang, X Yue, J Zahner, M Adams, ... (No Title), 2020 | 7 | 2020 |
| Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for invasive candidiasis in China D Chen, X Wan, E Kruger, C Chen, X Yue, L Wang, J Wu Journal of Medical Economics 21 (3), 301-307, 2018 | 6 | 2018 |
| 药物经济学评价的应用与重要性 岳晓萌， 丛博， 吴久鸿 首都医药, 16-17, 2014 | 6 | 2014 |
| Risk of severe COVID-19 outcomes among patients with immune-mediated inflammatory diseases or malignancies: a retrospective analysis of real-world data in the United States X Yue, Y Ye, YC Choi, D Zhang, WS Krueger Advances in Therapy 39 (12), 5413-5432, 2022 | 5 | 2022 |
| 中国药物经济学评价指南的应用与挑战 官海静， 岳晓萌， 吴久鸿 中国药学杂志 52 (13), 1188-1193, 2017 | 4 | 2017 |
| Factors associated with severe COVID-19 among patients with rheumatoid arthritis: a large, nationwide electronic health record cohort study in the United States Y Ye, X Yue, WS Krueger, LR Wegrzyn, AW Maniccia, KL Winthrop, ... Advances in Therapy 40 (9), 3723-3738, 2023 | 3 | 2023 |
| Impact of Season and Other Factors on Initiation, Discontinuation, and Switching of Systemic Drug Therapy in Patients with Psoriasis: A Retrospective Study H Liang, B Kirk, JM Polinski, X Yue, RD Kilpatrick, JM Gelfand JID Innovations 3 (2), 100171, 2023 | 2 | 2023 |
| Safety and cost-effectiveness of ponatinib versus other tyrosine kinase inhibitors as second-line therapy in patients with chronic myeloid leukemia in the United States X Yue, AL Hincapie, Y Li, JJ Guo Leukemia & Lymphoma 63 (4), 946-954, 2022 | 2 | 2022 |
| Characteristics and outcomes of COVID-19 patients with mature B-cell non-Hodgkin lymphomas (mB-cell NHL): a US Nationwide electronic health record (EHR) database study X Yue, D Hallett, Y Liu, R Iyengar, E Basa, H Yang Blood 138, 2418, 2021 | 2 | 2021 |
| Review of the international experiences in drug delisting policies YUE Xiaomeng, LI Yuxiang, Z Feili, JIA Fanghong, WU Jiuhong Herald of Medicine 40 (2), 158-162, 2021 | 2 | 2021 |
Ana L HincapieUniversity of CincinnatiVerified email at uc.edu
